Stock data
vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc. (VTVT) reported revenue of US$0.00M and net income of -US$26.97M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$0.00M | — | -US$32.81M | -US$26.97M | — |
| 2024 | US$1.02M | — | -US$24.18M | -US$18.46M | — |
| 2023 | US$0.00M | — | -US$25.50M | -US$20.25M | — |
| 2022 | US$2.02M | — | -US$22.54M | -US$19.16M | — |
| 2021 | US$4.00M | — | -US$21.66M | -US$12.99M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.00M | -US$13.05M | — |
| 2026-03-31 | US$36.84M | US$24.13M | — |
| 2025-12-31 | US$0.00M | -US$7.14M | — |
| 2025-09-30 | US$0.00M | -US$8.70M | — |
| 2025-06-30 | US$0.00M | -US$6.05M | — |
| 2025-03-31 | US$0.00M | -US$5.09M | — |
| 2024-12-31 | US$0.02M | -US$3.63M | — |
| 2024-09-30 | US$0.00M | -US$4.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.